C4 Therapeutics Inc (NASDAQ:CCCC) price closed lower on current market day and dropping -6.55% below its previous close.
A look at the daily price movement shows that the last close reads $1.68. Taking into account the 52-week price action we note that the stock hit a 52-week high of $7.66 and 52-week low of $1.09. The stock added 6.80% on its value in the past month.
The average estimate suggests sales growth for the quarter will likely fall by -55.30% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 22.75M for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow -36.08% below that which the company brought in the current year earning report.
Here is a look at the average analyst rating for the stock as represented on a scale of 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock is strong buy or strong sell respectively. Specifically, 3 analysts have assigned CCCC a recommendation rating as follows: 2 rate it as a Hold; 1 advise Buy while 0 analyst(s) assign an Overweight rating. 0 analyst(s) have tagged the C4 Therapeutics Inc (CCCC) stock as Underweight, with 0 recommending Sell. In general, analysts have rated the stock Hold, a scenario likely to bolster investors out for an opportunity to add to their holdings of the company’s shares.
The overview shows that CCCC’s price is at present 9.45% off the SMA20 and 8.97% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 53.44, with weekly volatility standing at 10.65%. The indicator jumps to 6.98% when calculated based on the past 30 days. C4 Therapeutics Inc (NASDAQ:CCCC)’s beta value is holding at 2.96, while the average true range (ATR) indicator is currently reading 0.15. Considering analysts have assigned the stock a price target range of $12-$12 as the low and high respectively, we find the trailing 12-month average consensus price target to be $12. Based on this estimate, we see that current price is roughly -664.33% off the estimated low and -664.33% off the forecast high. Investors will no doubt be excited to see the share price fall to $12, which is the median consensus price, and at that level CCCC would be -664.33% from current price.
Current records show that the company has 70.99M in outstanding shares. The insiders’ percentage holdings are 23.61% of outstanding shares while the percentage share held by institutions stands at 80.35%. But the -56.39% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
